Fluoride bioavailability from slow‐release sodium fluoride given with calcium citrate

Charles Y C Pak, Khashayar Sakhaee, Carol Parcel, John Poindexter, Beverley Adams, Abdillahi Bahar, Robert Beckley

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Clinical pharmacology of slow‐release sodium fluoride given with calcium citrate was examined in acute and long‐term studies. Following a single oral administration of 50 mg slow‐release sodium fluoride, a peak serum fluoride concentration (Cmax) of 184 ng/ml was reached in 2 h; thereafter, serum fluoride concentration declined with a T1/2 of 5.9 h. The concurrent administration of calcium citrate (400 mg calcium) gave an equivalent Tmax (time required to attain Cmax) and T1/2, but a lower Cmax of 135 ng/ml. The coadministration of a meal with fluoride also reduced Cmax but increased Tmax. The area under the serum concentration curve of slow‐release sodium fluoride was reduced 17‐27% by a meal or calcium citrate. Thus, calcium citrate reduced fluoride absorption and peak fluoride concentration in serum of slow‐release sodium fluoride but did not affect the time required to reach peak concentration or the rate of subsequent decline. The effect of a meal was similar, except for a longer period required to reach peak serum concentration. During long‐term administration of 25 mg slow‐release sodium fluoride coadministered with 400 mg calcium as calcium citrate on a twice daily schedule, the trough level of serum fluoride could be kept between 95 and 190 ng/ml, believed to be the therapeutic window.

Original languageEnglish (US)
Pages (from-to)857-862
Number of pages6
JournalJournal of Bone and Mineral Research
Issue number8
StatePublished - Aug 1990

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine


Dive into the research topics of 'Fluoride bioavailability from slow‐release sodium fluoride given with calcium citrate'. Together they form a unique fingerprint.

Cite this